CONATUS PHARMACEUTICALS INC's ticker is and the CUSIP is 20600T958. A total of 3 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,000 | -96.2% | 9,100 | -81.5% | 0.00% | -100.0% |
| Q1 2019 | $53,000 | -50.9% | 49,100 | -21.7% | 0.00% | 0.0% |
| Q4 2018 | $108,000 | +42.1% | 62,700 | +378.6% | 0.00% | 0.0% |
| Q3 2018 | $76,000 | +58.3% | 13,100 | +18.0% | 0.00% | – |
| Q2 2018 | $48,000 | +37.1% | 11,100 | +85.0% | 0.00% | – |
| Q1 2018 | $35,000 | -75.0% | 6,000 | -80.1% | 0.00% | -100.0% |
| Q4 2017 | $140,000 | +6.9% | 30,200 | +26.4% | 0.00% | 0.0% |
| Q3 2017 | $131,000 | -73.2% | 23,900 | -71.8% | 0.00% | -80.0% |
| Q2 2017 | $488,000 | -4.7% | 84,800 | -4.4% | 0.01% | -16.7% |
| Q1 2017 | $512,000 | +20.2% | 88,700 | +9.6% | 0.01% | +50.0% |
| Q4 2016 | $426,000 | +2405.9% | 80,900 | +840.7% | 0.00% | – |
| Q3 2016 | $17,000 | -54.1% | 8,600 | -52.5% | 0.00% | – |
| Q2 2016 | $37,000 | -17.8% | 18,100 | -13.8% | 0.00% | -100.0% |
| Q1 2016 | $45,000 | -25.0% | 21,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $60,000 | +106.9% | 21,000 | +223.1% | 0.00% | – |
| Q3 2015 | $29,000 | -80.5% | 6,500 | -77.5% | 0.00% | -100.0% |
| Q2 2015 | $149,000 | +1.4% | 28,900 | +39.6% | 0.00% | 0.0% |
| Q1 2015 | $147,000 | +332.4% | 20,700 | +322.4% | 0.00% | +100.0% |
| Q4 2014 | $34,000 | -71.9% | 4,900 | -75.3% | 0.00% | -50.0% |
| Q3 2014 | $121,000 | +210.3% | 19,800 | +360.5% | 0.00% | +100.0% |
| Q2 2014 | $39,000 | – | 4,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 6,500 | $29,000 | 0.00% |
| SIMPLEX TRADING, LLC | 37 | $5,000 | 0.00% |